0 XP 0   0   0  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Pharma Mar S.A. - Trending symbols

Latest News of Pharma Mar S.A.

DateTitleRead
2025-06-17
11:35
Global Growth Companies With High Insider Ownership June 2025Read



Trends

 2024-03-312024-06-302024-09-302024-12-312025-03-31
Net Income 2,300-1,0631,2372,6673,90414,78018,684-22,633-3,949
Net Income from Continuing Operations 2,300-1,0631,2372,6673,90414,78018,684-22,633-3,949
EBIT -184-4,934-5,118819-4,2993,569-7306,1885,458
Operating Income -184-4,992-5,176877-4,2993,569-7306,2115,481
Net Interest Income 1,754-1,6261281,4011,529-598931-2,526-1,595
Long-term Assets Other 109,671-4,448105,223-105,2230124,855124,855-124,8550
Net Debt -76,32343,931-32,3925,995-26,3979,741-16,65621,2074,551
EBITDA 23,658-14,5839,0753,79212,867-4,2028,665-10,064-1,399
Income before Tax 43,557-22,93420,623-8,63111,9922,00413,996-16,817-2,821
Total Other Income Expense Net 1961,4131,6095532,162-212,141-8,334-6,193
Interest Expense 5,489-3,9691,5206422,162-212,141-9,554-7,413
Cost of Revenue 3,6311,5555,186-1,3973,789-1483,641-3,662-21

Comments

How you think about this?

Leave a comment

Stay informed about Pharma Mar S.A..

Receive notifications about Pharma Mar S.A. in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.